URL of this page: https://medlineplus.gov/genetics/gene/scn8a/

SCN8A gene

sodium voltage-gated channel alpha subunit 8
From Genetics Home Reference. Learn more

Normal Function

The SCN8A gene belongs to a family of genes that provide instructions for making sodium channels. These channels allow positively charged sodium (Na) atoms (sodium ions) to pass into cells; they play a key role in a cell's ability to generate and transmit electrical signals.

The SCN8A gene provides instructions for making one part (the alpha subunit) of a sodium channel called Nav1.6. The alpha subunit forms the hole (pore) in the cell membrane through which sodium ions flow. Nav1.6 channels are primarily found in the nerve cells (neurons) of the brain and spinal cord (central nervous system) and neurons that connect the central nervous system to muscles and sensory cells that detect sensations such as touch, pain, heat, and sound (the peripheral nervous system). Nav1.6 channels control the flow of sodium ions into cells, which makes it possible for neurons to communicate by generating and transmitting electrical signals.

Health Conditions Related to Genetic Changes

SCN8A-related epilepsy with encephalopathy

More than 100 mutations in the SCN8A gene have been found to cause SCN8A-related epilepsy with encephalopathy. This condition is characterized by recurrent seizures (epilepsy), abnormal brain function (encephalopathy), and intellectual disability. The signs and symptoms of this condition typically begin in infancy.

Most of these SCN8A gene mutations change a single protein building block (amino acid) in the Nav1.6 channel. The mutations that cause SCN8A-related epilepsy with encephalopathy result in altered channels that stay open longer than usual, which increases the flow of sodium ions into neurons. The persistently open channels abnormally increase electrical signals, which can lead to excess activation (excitation) of neurons in the brain. This increased neuronal activity leads to seizures in people with SCN8A-related epilepsy with encephalopathy.

It is unknown how SCN8A gene mutations lead to intellectual disability, movement problems, and the other features of SCN8A-related epilepsy with encephalopathy. Because some affected children experience the loss of previously acquired skills (developmental regression) after the onset of seizures, it has been suggested that the seizures may impair brain function, but it is unclear if that is the case.

More About This Health Condition

Lennox-Gastaut syndrome

MedlinePlus Genetics provides information about Lennox-Gastaut syndrome

More About This Health Condition

Other disorders

Mutations in the SCN8A gene have been found to cause intellectual disability and movement problems in some individuals. Unlike the mutations that cause SCN8A-related epilepsy with encephalopathy (described above), the SCN8A gene mutations that cause this condition result in the production of a Nav1.6 sodium channel that is less active than normal, resulting in a decrease in the flow of sodium into neurons. This change does not increase neuronal signaling, so individuals with these mutations do not develop seizures. Researchers suspect that decreased neuronal signaling in the part of the brain that coordinates movement is the likely cause of the movement problems.

Other SCN8A gene mutations can cause movement problems and seizures called benign infantile seizures, which usually develop in the first year of life and stop by age 3. Unlike most other individuals with SCN8A gene mutations, these individuals have normal intellectual function. It is unknown why some SCN8A gene mutations cause these milder signs and symptoms while other mutations cause the more severe features of SCN8A-related epilepsy with encephalopathy.

Other Names for This Gene

  • BFIS5
  • CERIII
  • CIAT
  • hNa6/Scn8a voltage-gated sodium channel
  • NaCh6
  • Nav1.6
  • sodium channel, voltage gated, type VIII, alpha subunit
  • voltage-gated sodium channel subunit alpha Nav1.6
  • voltage-gated sodium channel type VIII alpha protein

Additional Information & Resources

Tests Listed in the Genetic Testing Registry

Scientific Articles on PubMed

Catalog of Genes and Diseases from OMIM

Research Resources

References

  • Butler KM, da Silva C, Shafir Y, Weisfeld-Adams JD, Alexander JJ, Hegde M, Escayg A. De novo and inherited SCN8A epilepsy mutations detected by gene panel analysis. Epilepsy Res. 2017 Jan;129:17-25. doi: 10.1016/j.eplepsyres.2016.11.002. Epub 2016 Nov 6. Citation on PubMed or Free article on PubMed Central
  • O'Brien JE, Meisler MH. Sodium channel SCN8A (Nav1.6): properties and de novo mutations in epileptic encephalopathy and intellectual disability. Front Genet. 2013 Oct 28;4:213. doi: 10.3389/fgene.2013.00213. Review. Citation on PubMed or Free article on PubMed Central
  • Ohba C, Kato M, Takahashi S, Lerman-Sagie T, Lev D, Terashima H, Kubota M, Kawawaki H, Matsufuji M, Kojima Y, Tateno A, Goldberg-Stern H, Straussberg R, Marom D, Leshinsky-Silver E, Nakashima M, Nishiyama K, Tsurusaki Y, Miyake N, Tanaka F, Matsumoto N, Saitsu H. Early onset epileptic encephalopathy caused by de novo SCN8A mutations. Epilepsia. 2014 Jul;55(7):994-1000. doi: 10.1111/epi.12668. Epub 2014 Jun 2. Citation on PubMed
  • Wagnon JL, Barker BS, Hounshell JA, Haaxma CA, Shealy A, Moss T, Parikh S, Messer RD, Patel MK, Meisler MH. Pathogenic mechanism of recurrent mutations of SCN8A in epileptic encephalopathy. Ann Clin Transl Neurol. 2015 Dec 21;3(2):114-23. doi: 10.1002/acn3.276. eCollection 2016 Feb. Citation on PubMed or Free article on PubMed Central
From Genetics Home Reference

Genetics Home Reference has merged with MedlinePlus. Genetics Home Reference content now can be found in the "Genetics" section of MedlinePlus. Learn more

The resources on this site should not be used as a substitute for professional medical care or advice. Users with questions about a personal health condition should consult with a qualified healthcare professional.